Page 71 - GPD-2-1

Gene & Protein in Disease Pyroptosis-related LncRNAs in pediatric AML

6. Li L, Jiang M, Qi L, et al., 2021, Pyroptosis, a new bridge to 18. Rowshanravan B, Halliday N, Sansom DM, 2018, CTLA-4:
tumor immunity (in eng). Cancer Sci, 112(10): 3979–3994. A moving target in immunotherapy (in eng). Blood, 131(1):
58–67.
https://doi.org/10.1111/cas.15059
https://doi.org/10.1182/blood-2017-06-741033
7. Fang Y, Tian S, Pan Y, et al., 2020, Pyroptosis: A new frontier
in cancer (in eng). Biomed Pharmacother, 121: 109595. 19. Maruhashi T, Sugiura D, Okazaki IM, et al., 2020, LAG-3:
From molecular functions to clinical applications (in eng).
https://doi.org/10.1016/j.biopha.2019.109595
J Immunother Cancer, 8(2): e001014.
8. Xia X, Wang X, Cheng Z, et al., 2019, The role of pyroptosis https://doi.org/10.1136/jitc-2020-001014
in cancer: Pro-cancer or pro-“host”? (in eng). Cell Death
Dis, 10(9): 650. 20. Zang K, Hui L, Wang M, et al., 2021, TIM-3 as a prognostic
marker and a potential immunotherapy target in human
https://doi.org/10.1038/s41419-019-1883-8 malignant tumors: A meta-analysis and bioinformatics
9. Johnson DC, Taabazuing CY, Okondo MC, et al., 2018, validation (in eng). Front Oncol, 11: 579351.
DPP8/DPP9 inhibitor-induced pyroptosis for treatment of https://doi.org/10.3389/fonc.2021.579351
acute myeloid leukemia (in eng). Nat Med, 24(8): 1151–1156.
21. Li L, Feng Q, Wang X, 2020, PreMSIm: An R package for
https://doi.org/10.1038/s41591-018-0082-y predicting microsatellite instability from the expression
10. Razmara M, Srinivasula SM, Wang L, et al., 2002, CARD-8 profiling of a gene panel in cancer (in eng). Comput Struct
protein, a new CARD family member that regulates Biotechnol J, 18: 668–675.
caspase-1 activation and apoptosis (in eng). J Biol Chem, https://doi.org/10.1016/j.csbj.2020.03.007
277(16): 13952–13958.
22. Garzon R, Volinia S, Papaioannou D, et al., 2014, Expression
https://doi.org/10.1074/jbc.M107811200 and prognostic impact of lncRNAs in acute myeloid
11. Luo X, Zhang X, Gan L, et al., 2018, The outer membrane leukemia (in eng). Proc Natl Acad Sci U S A, 111(52): 18679–
protein Tp92 of Treponema pallidum induces human 18684.
mononuclear cell death and IL-8 secretion (in eng). J Cell https://doi.org/10.1073/pnas.1422050112
Mol Med, 22(12): 6039–6054.
23. Liu J, Geng R, Ni S, et al., 2022, Pyroptosis-related lncRNAs
https://doi.org/10.1111/jcmm.13879 are potential biomarkers for predicting prognoses and
12. Bhan A, Soleimani M, Mandal SS, 2017, Long noncoding immune responses in patients with UCEC (in eng). Mol
RNA and cancer: A new paradigm (in eng). Cancer Res, Ther Nucleic Acids, 27: 1036–1055.
77(15): 3965–3981. https://doi.org/10.1016/j.omtn.2022.01.018
https://doi.org/10.1158/0008-5472.Can-16-2634 24. Ping L, Zhang K, Ou X, et al., 2021, A novel pyroptosis-
13. Bridges MC, Daulagala AC, Kourtidis A, 2021, LNCcation: associated long non-coding RNA signature predicts
lncRNA localization and function (in eng). J Cell Biol, prognosis and tumor immune microenvironment of patients
220(2): e202009045. with breast cancer (in eng). Front Cell Dev Biol, 9: 727183.
https://doi.org/10.1083/jcb.202009045 https://doi.org/10.3389/fcell.2021.727183
14. He D, Zheng J, Hu J, et al., 2020, Long non-coding RNAs and 25. Guo M, Xiao ZD, Dai Z, et al., 2020, The landscape of
pyroptosis (in eng). Clin Chim Acta, 504: 201–208. long noncoding RNA-involved and tumor-specific fusions
across various cancers (in eng). Nucleic Acids Res, 48(22):
https://doi.org/10.1016/j.cca.2019.11.035 12618–12631.
15. Weber CE, Kuo PC, 2012, The tumor microenvironment (in https://doi.org/10.1093/nar/gkaa1119
eng). Surg Oncol, 21(3): 172–177.
26. Lu Z, Tang F, Li Z, et al., 2022, Prognosis risk model based
https://doi.org/10.1016/j.suronc.2011.09.001 on pyroptosis-related lncRNAs for bladder cancer (in eng).
16. Newman AM, Liu CL, Green MR, et al., 2015, Robust Dis Markers, 2022: 7931393.
enumeration of cell subsets from tissue expression profiles https://doi.org/10.1155/2022/7931393
(in eng). Nat Methods, 12(5): 453–457.
27. Aran D, Sirota M, Butte AJ, 2015, Systematic pan-cancer
https://doi.org/10.1038/nmeth.3337 analysis of tumour purity (in eng). Nat Commun, 6: 8971.
17. Ohaegbulam KC, Assal A, Lazar-Molnar E, et al., 2015, https://doi.org/10.1038/ncomms9971
Human cancer immunotherapy with antibodies to the PD-1 28. Abril-Rodriguez G, RibasA, 2017, SnapShot: Immune
and PD-L1 pathway (in eng). Trends Mol Med, 21(1): 24–33.
checkpoint inhibitors (in eng). Cancer Cell, 31(6):
https://doi.org/10.1016/j.molmed.2014.10.009 848–848.e1.

Volume 2 Issue 1 (2023) 16 https://doi.org/10.36922/gpd.v2i1.230